0001924356-22-000002.txt : 20220421 0001924356-22-000002.hdr.sgml : 20220421 20220421172314 ACCESSION NUMBER: 0001924356-22-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20220421 DATE AS OF CHANGE: 20220421 EFFECTIVENESS DATE: 20220421 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aurion Biotech, Inc. CENTRAL INDEX KEY: 0001924356 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-442906 FILM NUMBER: 22842411 BUSINESS ADDRESS: STREET 1: 117 E. LOUISA STREET STREET 2: #561 CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: 206-701-5840 MAIL ADDRESS: STREET 1: 117 E. LOUISA STREET STREET 2: #561 CITY: SEATTLE STATE: WA ZIP: 98102 D 1 primary_doc.xml X0708 D LIVE 0001924356 Aurion Biotech, Inc. 117 E. LOUISA STREET #561 SEATTLE WA WASHINGTON 98102 206-701-5840 DELAWARE CorneaX Inc. None Corporation true 2021 GREG KUNST 117 E. LOUISA #561 SEATTLE WA WASHINGTON 98102-3203 Executive Officer Director DAVID ROSTOV 117 E. LOUISA #561 SEATTLE WA WASHINGTON 98102-3203 Executive Officer ARNAUD LACOSTE 117 E. LOUISA #561 SEATTLE WA WASHINGTON 98102-3203 Executive Officer LINK WILLIAM 117 E. LOUISA #561 SEATTLE WA WASHINGTON 98102-3203 Director PATRICK LALLY 117 E. LOUISA #561 SEATTLE WA WASHINGTON 98102-3203 Director ANDREW ELBARDISSI 117 E. LOUISA #561 SEATTLE WA WASHINGTON 98102-3203 Director JEANNETTE BANKES 117 E. LOUISA #561 SEATTLE WA WASHINGTON 98102-3203 Director TOM FRINZI 117 E. LOUISA #561 SEATTLE WA WASHINGTON 98102-3203 Director CHRISTINE MCCAULEY 117 E. LOUISA #561 SEATTLE WA WASHINGTON 98102-3203 Director Biotechnology Decline to Disclose 06c false 2022-04-05 false true false 0 Raymond James 705 None None 320 Park Avenue, Floor 10 New York NY NEW YORK 10022 CT CONNECTICUT MN MINNESOTA MA MASSACHUSETTS NC NORTH CAROLINA FL FLORIDA MD MARYLAND GA GEORGIA WA WASHINGTON NY NEW YORK CO COLORADO CA CALIFORNIA false 120283128 55293147 64989981 false 9 4000000 0 0 false Aurion Biotech, Inc. /s/ David Rostov David Rostov Chief Financial Officer 2022-04-21